Cargando…

Immune dysregulation in extranodal NK/T cell lymphomas: potential roles in pathogenesis and immunotherapy

Detalles Bibliográficos
Autores principales:	Polprasert, Chantana, Wudhikarn, Kitsada, Rojnuckarin, Ponlapat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721455/ https://www.ncbi.nlm.nih.gov/pubmed/34776415 http://dx.doi.org/10.5045/br.2021.2021123

Ejemplares similares

Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes
por: Hattakitpanitchakul, Saroj, et al.
Publicado: (2021)

A Randomized Multicenter Trial Comparing Low-Dose Prednisolone Versus Observation for Prevention of Recurrences in Adult Immune Thrombocytopenia
por: Pirunsarn, Arunrat, et al.
Publicado: (2018)

Factors associated with erythropoiesis-stimulating agent hyporesponsiveness anemia in chronic kidney disease patients
por: Amnuay, Kamalas, et al.
Publicado: (2019)

P1189: ENDOTHELIAL ACTIVATION AND STRESS INDEX IS AN INDEPENDENT PROGNOSTIC FACTOR OF DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH STANDARD IMMUNOCHEMOTHERAPY
por: Thanhakun, Ronakrit, et al.
Publicado: (2023)

P1238: GERMLINE HAVCR2 MUTATIONS AND THEIR RELATION TO THE CLINICAL SPECTRUM OF SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA AND HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: RESULTS FROM A MULTICENTER STUDY
por: Polprasert, Chantana, et al.
Publicado: (2023)

Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis
por: Moonla, Chatphatai, et al.
Publicado: (2023)

Novel Immunotherapy Options for Extranodal NK/T-Cell Lymphoma
por: Hu, Boyu, et al.
Publicado: (2018)

Cold agglutinin disease following SARS‐CoV‐2 and Mycoplasma pneumoniae co‐infections
por: Moonla, Chatphatai, et al.
Publicado: (2020)

Extranodal NK/T cell lymphoma
por: Jeong, Seong Hyun
Publicado: (2020)

Extranodal T- and NK-cell lymphomas
por: de Leval, Laurence, et al.
Publicado: (2022)

An autopsy case of primary extranodal NK/T cell lymphoma (extranodal NK/T-cell lymphoma) of the bile duct
por: Ito, Hiroyuki, et al.
Publicado: (2019)

Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies
por: Zhou, Ting, et al.
Publicado: (2020)

Laryngeal recurrence of extranodal NK/T cell lymphoma
por: Kumai, Takumi, et al.
Publicado: (2021)

Leukemic presentation of extranodal NK/T‐cell lymphoma
por: Hafeez, Safina, et al.
Publicado: (2021)

Extranodal NK/T-cell Lymphoma Mimicking Erythema Multiforme
por: Xia, Ying, et al.
Publicado: (2015)

Extranodal NK/T Cell Lymphoma Causing Cardiorespiratory Failure
por: Li, Yiting, et al.
Publicado: (2016)

Extranodal NK/T-cell Lymphoma Mimicking Granulomatous Myositis
por: Kawaguchi, Norihiko, et al.
Publicado: (2018)

Molecular pathogenic pathways in extranodal NK/T cell lymphoma
por: de Mel, Sanjay, et al.
Publicado: (2019)

Extranodal NK/T-Cell Lymphoma Mimicking an Infectious Granuloma
por: Suh, Min Song, et al.
Publicado: (2019)

The Pathologic and Genetic Characteristics of Extranodal NK/T-Cell Lymphoma
por: Kim, Hyunsung, et al.
Publicado: (2022)

Extranodal NK/T Cell Lymphoma Mimicking Behçet's Syndrome
por: Wang, Youyang, et al.
Publicado: (2021)

Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma
por: Major, Ajay, et al.
Publicado: (2023)

Extranodal lymphoma: pathogenesis, diagnosis and treatment
por: Yang, Hua, et al.
Publicado: (2023)

Characterization of the humoral immune response to the EBV proteome in extranodal NK/T-cell lymphoma
por: Liu, Zhiwei, et al.
Publicado: (2021)

EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma
por: Lee, Ji Yun, et al.
Publicado: (2021)

Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy
por: Wudhikarn, Kitsada, et al.
Publicado: (2022)

Extranodal NK/T-Cell Lymphomas: The Role of Natural Killer Cells and EBV in Lymphomagenesis
por: Saleem, Atif, et al.
Publicado: (2020)

Extranodal NK/T-cell lymphoma presenting with primary cardiac involvement
por: Lepeak, Lisa M., et al.
Publicado: (2011)

Icaritin induces lytic cytotoxicity in extranodal NK/T-cell lymphoma
por: Wu, Ting, et al.
Publicado: (2015)

Multifocal primary cutaneous extranodal NK/T lymphoma nasal type
por: de Vasconcelos, Pedro, et al.
Publicado: (2016)

Educational Case: Extranodal NK/T-Cell Lymphoma, Nasal Type
por: Jia, Yue, et al.
Publicado: (2019)

New Approaches for Treatment of Advanced Extranodal NK/T-Cell Lymphoma
por: Yi, Wu, et al.
Publicado: (2022)

Treatment of extranodal NK/T-cell lymphoma: From past to future
por: Yan, Zheng, et al.
Publicado: (2023)

Composite Lymphoma Comprising Extranodal NK/T-Cell Lymphoma and Diffuse Large B-Cell Lymphoma
por: Nagai, Shin, et al.
Publicado: (2018)

Extranodal NK/T-Cell Lymphoma: Toward the Identification of Clinical Molecular Targets
por: Schmitt, Christian, et al.
Publicado: (2011)

Extranodal nasal-type NK/T-cell lymphoma of the palate and paranasal sinuses
por: Nikolaos, Nikitakis, et al.
Publicado: (2012)

Nasal-type extranodal T-cell/NK lymphoma in association with hemophagocytic syndrome
por: Guedes, Juliana Chaves Ruiz, et al.
Publicado: (2018)

Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis
por: Liu, Yi-Zhen, et al.
Publicado: (2019)

Extranodal NK/T Cell Lymphoma with Destruction of the Uvulae: A Case Report
por: Jabbari Azad, Farahzad, et al.
Publicado: (2017)

Extranodal NK/T-cell lymphoma, nasal type with extensive cardiopulmonary involvement
por: Marques-Piubelli, Mario L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_avbm1kjrpljakdpfs7j7agdr4h